India Resurgence Fund (IndiaRF), an India-focused investment platform promoted by Piramal Enterprises and Bain Capital, has invested Rs 525 crore (about $64 million) in Ivy Health and Life Sciences, marking its first investment in the healthcare segment.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
